X4 Pharmaceuticals X4 Pharmaceuticals X4 Pharmaceuticals X4 Pharmaceuticals
  • About
  • Our Medicine
  • Science
    & Pipeline
  • Patients
  • Healthcare
    Professionals
  • Investors
    • Company Overview
    • News Releases
    • Events & Presentations
    • Stock Information
    • Analyst Coverage
    • Governance
    • SEC Filings
    • Investor FAQs
  • Careers
X4 Pharmaceuticals X4 Pharmaceuticals
  • About
  • Our Medicine
  • Science
    & Pipeline
  • Patients
  • Healthcare
    Professionals
  • Investors
    • Company Overview
    • News Releases
    • Events & Presentations
    • Stock Information
    • Analyst Coverage
    • Governance
    • SEC Filings
    • Investor FAQs
  • Careers

Rare

Resolve.

Driving progress for people living with rare immune disorders ABBEY Living with Chronic Neutropenia

recent news

  • X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    August 15, 2025
  • X4 Pharmaceuticals Announces Closing of Upsized $85 Million Private Placement
    August 13, 2025
  • X4 Pharmaceuticals Announces $60 Million Equity Financing with Concurrent Changes in Management and Board Leadership
    August 12, 2025
More News

quick links

  • About
  • Patients
  • Investors
  • Careers
X4 Pharmaceuticals Logo

contact

X4 Pharmaceuticals
61 North Beacon Street
4th Floor
Boston, MA 02134
Phone: 857.529.8300

 

X4 Pharmaceuticals (Austria) GmbH
Hohenstaufengasse 9/DG
1010 Vienna, Austria
Phone: +43 676 89 85 43 700
© Copyright 2025 X4 Pharmaceuticals. All Rights Reserved.  Terms of Use  |  Privacy  |  Compliance and Ethics